De la Chapelle syndrome: clinical and laboratory characteristics of 4 patients
https://doi.org/10.14341/probl2017632124-126
Abstract
We describe 4 cases of 46,XX testicular disorder of sex development. Depending on the presence of the SRY gene, two variants of this disease are distinguished: SRY-positive and SRY-negative ones. The SRY (sex-determining region Y) gene is involved in differentiation of Sertoli cells and development of the testes. The pathogenesis of the disease in SRY-positive patients is related to translocation of the SRY gene from the Y chromosome to the X chromosome. The pathogenesis of the disease in SRY-negative patients is associated with overexpression of genes (SOX9, SOX3, etc.) responsible for the development of male genitalia or inadequate gene expression (WNT4, RSPO1, etc.) responsible for the development of female genitalia. The patients had a hermaphroditic genital structure with a masculinization score (EMS) of 6 and 11 and were SRY-negative in 50% of cases; 50% of the patients were SRY-positive with full masculinization, microorchidism, and gynecomastia. All children underwent a hormonal examination in the neutral and pubertal periods. Patients who reached pubertal age developed partial and total hypergonadotropic hypogonadism. The patients have had no need in substitution therapy with testosterone. One of the patients underwent a semiological analysis that revealed necrozoospermia and oligoasthenoteratozoospermia. A SRY-negative patient with cryptorchidism underwent biopsy of the cryptorchid gonad; no Leydig cells were found.
About the Authors
Ekaterina S. SannikovaRussian Medical Academy of Continuous Professional Education
Russian Federation
MD
Oleg Yu. Latyshev
Russian Medical Academy of Continuous Professional Education
Russian Federation
MD, PhD
Lubov N. Samsonova
Russian Medical Academy of Continuous Professional Education
Russian Federation
MD, PhD, professor
Elena V. Kiseleva
Russian Medical Academy of Continuous Professional Education
Russian Federation
MD, PhD
Goar F. Okminyan
Russian Medical Academy of Continuous Professional Education
Russian Federation
MD, PhD
Elvira P. Kasatkina
Russian Medical Academy of Continuous Professional Education
Russian Federation
MD, PhD, professor
References
1. Alves C, Braid Z, Coeli FB, Mello MPd. 46,XX Male — Testicular Disorder of Sexual Differentiation (DSD): hormonal, molecular and cytogenetic studies. Arq Bras Endocrinol Metab. 2010;54(8):685-689. doi: 10.1590/s0004-27302010000800004.
2. Li T-F, Wu Q-Y, Zhang C, et al. 46,XX testicular disorder of sexual development with SRY-negative caused by some unidentified mechanisms: a case report and review of the literature. BMC Urol. 2014;14(1). doi: 10.1186/1471-2490-14-104.
3. de la Chapelle A. The etiology of maleness in XX men. Hum Genet. 1981;58(1):105-116. doi: 10.1007/bf00284157.
4. Vorona E, Zitzmann M, Gromoll J, et al. Clinical, Endocrinological, and Epigenetic Features of the 46,XX Male Syndrome, Compared with 47,XXY Klinefelter Patients. J Clin Endocr Metab. 2007;92(9):3458-3465. doi: 10.1210/jc.2007-0447.
5. Abbas N, Toublanc J, Boucekkine C, et al. A possible common origin of «Y-negative» human XX males and XX true hermaphrodites. Hum Genet. 1990;84(4). doi: 10.1007/bf00196234.
6. Boucekkine C, Toublanc JE, Abbas N, et al. Clinical and anatomical spectrum in XX sex reversed patients. Relationship to the presence of Y specific DNA-sequences. Clin Endocrinol (Oxf). 1994;40(6):733-742. doi: 10.1111/j.1365-2265.1994.tb02506.x.
7. Wu Q-Y, Li N, Li W-W, et al. Clinical, molecular and cytogenetic analysis of 46, XX testicular disorder of sex development with SRY-positive. BMC Urol. 2014;14(1). doi: 10.1186/1471-2490-14-70.
Supplementary files
Review
For citations:
Sannikova E.S., Latyshev O.Yu., Samsonova L.N., Kiseleva E.V., Okminyan G.F., Kasatkina E.P. De la Chapelle syndrome: clinical and laboratory characteristics of 4 patients. Problems of Endocrinology. 2017;63(2):124-126. https://doi.org/10.14341/probl2017632124-126

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).